Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert J Behrens

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|October 17, 2003
Complexity of Langerhans' cell histiocytosisRobert J Behrens, David S Cooper
American Journal of Therapeutics|May 21, 2003
Pulmonary toxicity during prostate cancer treatment with docetaxel and thalidomideRobert J Behrens, James L Gulley, William L Dahut
Cleveland Clinic Journal of Medicine|March 14, 2002
Oncologic emergencies for the internistWilliam S Krimsky, Robert J Behrens, Gary J Kerkvliet
The Oncologist|March 14, 2022
N064A (Alliance): Phase II Study of Panitumumab, Chemotherapy, and External Beam Radiation in Patients with Locally Advanced Pancreatic AdenocarcinomaThorvardur R Halfdanarson, Nathan R Foster, George P Kim, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 11, 2013
Assessment of long-term rectal function in patients who received pelvic radiotherapy: a pooled North Central Cancer Treatment Group trial analysis, N09C1Lindsay C Brown, Pamela J Atherton, Michelle A Neben-Wittich, et al.
Plos One|July 21, 2012
Gemcitabine and irinotecan as first-line therapy for carcinoma of unknown primary: results of a multicenter phase II trialShernan G Holtan, Preston D Steen, Nathan R Foster, et al.
Cancer Investigation|February 25, 2011
Exploring therapeutic decisions in elderly patients with non-small cell lung cancer: results and conclusions from North Central Cancer Treatment Group Study N0222Heidi Mc Kean, Philip J Stella, Shauna L Hillman, et al.
Cancer|March 13, 2014
North Central Cancer Treatment Group/Alliance trial N08CA-the use of glutathione for prevention of paclitaxel/carboplatin-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled studyAlexis D Leal, Rui Qin, Pamela J Atherton, et al.
Clinical Breast Cancer|October 23, 2012
North central cancer treatment group (NCCTG) N0537: phase II trial of VEGF-trap in patients with metastatic breast cancer previously treated with an anthracycline and/or a taxaneKostandinos Sideras, Amylou C Dueck, Timothy J Hobday, et al.
The Oncologist|April 9, 2014
Prospective multicenter study of the impact of oncotype DX colon cancer assay results on treatment recommendations in stage II colon cancer patientsGeetika Srivastava, Lindsay A Renfro, Robert J Behrens, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|October 17, 2003
Complexity of Langerhans' cell histiocytosisRobert J Behrens, David S Cooper
American Journal of Therapeutics|May 21, 2003
Pulmonary toxicity during prostate cancer treatment with docetaxel and thalidomideRobert J Behrens, James L Gulley, William L Dahut
Cleveland Clinic Journal of Medicine|March 14, 2002
Oncologic emergencies for the internistWilliam S Krimsky, Robert J Behrens, Gary J Kerkvliet
The Oncologist|March 14, 2022
N064A (Alliance): Phase II Study of Panitumumab, Chemotherapy, and External Beam Radiation in Patients with Locally Advanced Pancreatic AdenocarcinomaThorvardur R Halfdanarson, Nathan R Foster, George P Kim, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 11, 2013
Assessment of long-term rectal function in patients who received pelvic radiotherapy: a pooled North Central Cancer Treatment Group trial analysis, N09C1Lindsay C Brown, Pamela J Atherton, Michelle A Neben-Wittich, et al.
Plos One|July 21, 2012
Gemcitabine and irinotecan as first-line therapy for carcinoma of unknown primary: results of a multicenter phase II trialShernan G Holtan, Preston D Steen, Nathan R Foster, et al.
Cancer Investigation|February 25, 2011
Exploring therapeutic decisions in elderly patients with non-small cell lung cancer: results and conclusions from North Central Cancer Treatment Group Study N0222Heidi Mc Kean, Philip J Stella, Shauna L Hillman, et al.
Cancer|March 13, 2014
North Central Cancer Treatment Group/Alliance trial N08CA-the use of glutathione for prevention of paclitaxel/carboplatin-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled studyAlexis D Leal, Rui Qin, Pamela J Atherton, et al.
Clinical Breast Cancer|October 23, 2012
North central cancer treatment group (NCCTG) N0537: phase II trial of VEGF-trap in patients with metastatic breast cancer previously treated with an anthracycline and/or a taxaneKostandinos Sideras, Amylou C Dueck, Timothy J Hobday, et al.
The Oncologist|April 9, 2014
Prospective multicenter study of the impact of oncotype DX colon cancer assay results on treatment recommendations in stage II colon cancer patientsGeetika Srivastava, Lindsay A Renfro, Robert J Behrens, et al.
Pageof 3